Online Safety Community

Medical Device Regulatory and Quality professionals need to have essential knowledge to manage drug and device combination product projects

Medical Device Regulatory and Quality professionals need to have essential knowledge to manage drug and device combination product projects for a number of valid reasons. One of the main reasons is that medical device regulatory and quality professionals are often responsible for overseeing the development of combination products that include small or large drug “active pharmaceutical ingredients” to achieve the clinical therapeutic effect.

In many pharmaceutical organizations, the medical device professional is often expected to take the lead role in overseeing all aspects of regulatory and quality compliance, including Chemistry, Manufacturing and Controls (CMC) aspects, particularly when the “primary mode of action” (PMOA) relates to the device component. It is here that Medical Device Regulatory and Quality professionals need to have essential knowledge to manage drug and device combination product projects, because Regulatory and Quality engineers are often ill-equipped to manage the CMC aspects of projects.

This is because being technically trained personnel; they have scant knowledge of even the basic functions of the chemical, molecular structural, drug manufacturing process and analytical methods associated with the "active pharmaceutical ingredient" component.

Need to be able to understand technical elements of medical devices and combination drugs

Yet, that medical Device Regulatory and Quality professionals need to have essential knowledge to manage drug and device combination product projects cannot be ruled out, because since subtle chemical issues are integrally related to product performance, they need to be able to understand technical elements of medical devices and combination drugs.

The professional in charge of Regulatory Affairs (RA) needs to have a clear understanding of how drug chemistry impacts drug/device performance. The RA Lead needs to have answers to questions relating to:

o  The proper storage and environmental condition for simple molecules, peptides, polypeptides and proteins

o  The ways in which the drug impurity levels change as the product is combined with the device components

o  The way “Quality by Design” (QbD) ensures drug performance

o  The methods by which an analytical method should be validated to meet FDA CDER requirements

o  The indicia of drug stability

Since it is questions such as these that frequently arise during FDA product evaluation, Medical Device Regulatory and Quality professionals need to have essential knowledge to manage drug and device combination product projects.

A major learning session to help understand these aspects

Compliance4All, a leading provider of professional trainings for all the areas of regulatory compliance, will organize a learning session to help understand these aspects, at which these and related aspects of managing drug and device combination product project will be imparted.

The speaker at this webinar is Robert Michalik J.D, RAC, a Massachusetts regulatory attorney and founder of RegulatoryPro.com, a consulting firm providing general and specialized services to the biopharmaceutical and medical device industries. To enrol for this webinar, please visit

http://www.compliance4all.com/control/w_product/~product_id=501077L...

Robert will familiarize participants with the basics of small molecule and larger molecule (protein chemistry) development and testing. Using this as the basis, he will offer real world practical situations that arise in this field, which will help participants to become aware of how to spot problems that are a routine occurrence in every product development program. Being able to spot a CMC problem is more important than having the knowledge to fix it, because the FDA does not expect a company to solve it, but rather that it understands how the agency locates the problem.

Robert will cover the following areas at this session:

Chemistry 101: A review of the basics

  • Molecular structure and its impact on drug activity (smaller molecules behave differently from larger molecules)
  • Techniques commonly used in drug synthesis, manufacturing and quality control testing.
  • CMC Regulatory Compliance: Brief but comprehensive review of the essentials
  • How to spot a CMC-related problem and what to do when you suspect one.
  • Case studies that illustrate common issues that arise relating to drug components in combination device products
  • FAQs and Essential follow-up reading for those who want more resources

Views: 19

Comment

You need to be a member of Online Safety Community to add comments!

Join Online Safety Community

Take our poll!

Take our poll!

Latest Activity

John Robinson posted a blog post

Regulations in the US and EU Dealing with Combination Products

Registering and maintaining combination products in the US and the EU is a bit tricky, because these are disparate markets that are governed by different sets of regulations which are independent of each other. So, any business that wants to market combination products into the US or the EU must be completely aware of the nature and meaning of all the regulations. Such businesses…See More
10 hours ago
Adam Fleaming posted blog posts
10 hours ago
Alex posted a blog post

3 essential electrical safety tips for new students

Living away from home for the first time is an exciting, invigorating, and pretty daunting experience. While your first days at uni will be the time of your life, living away from your parents also comes with a new set of challenges.Aside from cooking and cleaning, one thing we take for granted is our parents’ knowledge of how to keep us safe. Electrical safety, in particular, is something not many first-time students know a lot about, but electrical accidents are…See More
11 hours ago
Training Doyens posted events
11 hours ago

Forum

Occupational Health and Safety 5 Replies

Health and safety are important aspects of an organisation’s smooth and effective functioning.  Did you know that workplace health & safety injuries cost Australian businesses over $60 billion…Continue

Tags: Safety, and, Health, Occupational

Started by WHS Solutions. Last reply by Tara safe yesterday.

QlikView for its Safety Strategic Business Intelligence Solution Worldwide

QlikTech (NASDAQ:QLIK), a leading…Continue

Tags: Qlikview, safety

Started by nicolewells on Wednesday.

What's your favorite motivational/safety quote? 102 Replies

Favorite Motivational Quote: If you want something, you'll find a way - If not, you'll find an excuse.Favorite Safety Quote: Don't learn safety by accident!Continue

Started by Michelle Sears. Last reply by David Collins on Tuesday.

Business Intelligence with Big Data happens at Unipê

the college center of João Pessoa will preserve the 1st assembly at big records, geared toward professionals inside the regions of administration, economics, public control and facts technologies.…Continue

Tags: qliksensetraining, qliksenseonline, qliksense

Started by Soujanya Naganuri Nov 1.

Road Safety Solutions 13 Replies

The Road Safety Signs ,Barriers,Humps,Hazard Markers and Visual Warnings are some of the important marks to be observed. Signs such as "keep left",stop, "give way" should not be casually treated.…Continue

Tags: safety, gear, wear, Equipment, &

Started by Enna Henry. Last reply by Barry Oct 26.

Badge

Loading…

© 2017   Created by Safety Community.   Powered by

Badges  |  Report an Issue  |  Terms of Service